Healthcare Research | Market Insights & Strategic Analysis

The top 7 (US, EU4, UK, and Japan)  kyphoscoliosis markets  are expected to exhibit a CAGR of 2.65% during 2025-2035. Kyphoscoliosis is a type of spinal disorder or disease that is structurally complex due to its unique curvature in both the sagittal(lateral) and coronal frontal planes sagittal direction (kyphosis) and lateral scoliosis curvature. The market for kyphoscoliosis treatment as of 2025 is growing due to its profound presence, technological investments, and the shift towards more customized approaches in treatment. Soaring Cases and Market Growth With the condition becoming more common due to the increase of elderly people, a more sedentary lifestyle, and higher prevalence of spinal cord injuries, the prevalence of kyphoscoliosis is on the rise. Spinal injuries, which are frequently caused by injury or degenerative illness, can result in conditions such as kyphoscoliosis. For example, the New Zealand Spinal Trust reported an increase in sporting and recreational spi...

   The  critical limb ischemia market  reached a value of USD 1.4 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 2.7 Billion by 2035, exhibiting a growth rate (CAGR) of 6.37% during 2025-2035. Critical Limb Ischemia (CLI) is the most advanced and severe form of peripheral artery disease (PAD) wherein patients experience chronic ischemic pain at rest, and ulcerations, or render their limbs gangrenous. In 2025, the CLI global treatment market will grow exponentially due to its increasing prevalence, advancement in technologies, and rising awareness. Rising Incidence and Market Expansion The prevalence of CLI is on the rise due to the growing rate of diabetes mellitus, hypertensive conditions, and peripheral artery diseases. IDF Diabetes Atlas suggests that the global prevalence of diabetes in adults will significantly grow by the year 2045 which will severely contribute to the...

   The  bipolar disorder market  reached a value of USD 3.2 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 4.0 Billion by 2035, exhibiting a growth rate (CAGR) of 2.08% during 2025-2035. The market is expanding in 2025 and is expected to grow further in the following years due to factors including increased prevalence of bipolar disorder, innovation in the diagnostic methods, and new treatment options. Bipolar disorder as a mental health problem is still a challenge globally. From a clinical perspective, untreated bipolar disorder is chronic in nature because it tends to last over long periods of time due to cycles of mania and depressive episodes.  Rising Incidence and Market Expansion The prevalence of the disorder is rapidly increasing worldwide. It is estimated that approximately 4.4% of the adult population in the United States suffers from this disorder which come...

  The   generalized anxiety disorder market   reached a value of USD 1.9 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 3.8 Billion by 2035, exhibiting a growth rate (CAGR) of 6.43% during 2025-2035. Generalized Anxiety Disorder is one of the most common mental health illnesses GAD, and is marked by an inability to control worrying over a number of different areas in everyday life. The   generalized anxiety disorder market by 2025 seems to be on a huge uptrend because of increasing awareness, new treatment options, and new technology. GAD is becoming more common around the world. In Australia, approximately 3.4 million people suffering from the condition makes it the most prevalent mental health disorder in the country. This is true for other parts of the world as well, including North America and certain regions in the Asia-Pacific. Lifestyles like high stress and lack...

  The   rheumatoid arthritis market   reached a value of USD 28.0 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 35.4 Billion by 2035, exhibiting a growth rate (CAGR) of 2.17% during 2025-2035.  Rheumatoid Arthritis is an autoimmune condition characterized by chronic inflammation of the joints which causes pain and deformities in the joint. The revenue for the Rheumatoid Arthritis Market around the globe is expected to grow significantly as there are improved treatment options, newer technologies, and an increase in the number of patients suffering from the disorder. The demand and supply for resources in the RA markets are on the rise everywhere. One of the largest contributing factors would include the increase in the lifestyle ailments such as diet or lack of exercise which is leading to higher incidence of rheumatoid arthritis. There is also an increase in olde...

  The   psoriasis market   reached a value of USD 20.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 38.4 Billion by 2035, exhibiting a growth rate (CAGR) of 5.96% during 2025-2035. A chronic autoimmune condition which manifests itself with red, itchy, scaly patches on knees, elbows, trunk, and scalp, Psoriasis is a skin disorder. It arises when the immune system misfires and causes the skin cells to regenerate at an accelerated pace. The   proriasis market is growing significantly in 2025 owing to increasing disease awareness along with improved diagnostic rates and treatment technologies. The occurrence of psoriasis is on a steady increase globally. Its contributed factors include environmental elements, genetic make-up, lifestyle factors like smoking, and stress. Improved healthcare access is diagnosing more patients and hence reporting a larger number of cases...

   The   celiac disease market   reached a value of USD 631.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 1,476.2 Million by 2035, exhibiting a growth rate (CAGR) of 8.03% during 2025-2035. Celiac disease market is an autoimmune disorder in which the consumption of gluten results in injury to the small intestine. This damage interferes with normal nutrient absorption leading to various health complications such as gastrointestinal distress, weakness, and blood disorders like anemia. The rise in awareness and improvement in diagnostic methods is expected to propel the global celiac disease market growth markedly in 2025. Market expansion is heavily fueled by the rising celiac disease cases. The availability of better screening tests and education awareness is resulting in greater diagnosing across the globe. In the Asia Pacific region, some parts of India are experien...